A Phase III Study of BBI-608 in Combination With 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CRC).
This is an international multi-centre, prospective, open-label, randomized phase 3 trial of
the cancer stem cell pathway inhibitor napabucasin plus standard bi-weekly FOLFIRI versus
standard bi-weekly FOLFIRI in patients with previously treated metastatic colorectal cancer
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society